Wealthspire Advisors (Maryland)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$551K Sell
8,723
-1,198
-12% -$83.1K 0.02% 251
2020
Q2
$763K Sell
9,921
-440
-4% -$33.7K 0.05% 195
2020
Q1
$775K Buy
10,361
+1,467
+16% +$101K 0.07% 175
2019
Q4
$578K Sell
8,894
-1,160
-12% -$75.5K 0.04% 251
2019
Q3
$637K Buy
10,054
+1,153
+13% +$75.4K 0.05% 220
2019
Q2
$601K Sell
8,901
-2,130
-19% -$140K 0.05% 226
2019
Q1
$717K Buy
11,031
+414
+4% +$27.5K 0.05% 190
2018
Q4
$664K Sell
10,617
-1,694
-14% -$118K 0.06% 172
2018
Q3
$951K Buy
12,311
+305
+3% +$23K 0.08% 146
2018
Q2
$851K Sell
12,006
-859
-7% -$60.7K 0.08% 147
2018
Q1
$970K Buy
12,865
+559
+5% +$44.4K 0.09% 136
2017
Q4
$882K Buy
12,306
+48
+0.4% +$3.65K 0.09% 150
2017
Q3
$993K Sell
12,258
-629
-5% -$48.1K 0.11% 132
2017
Q2
$912K Buy
12,887
+2,161
+20% +$144K 0.11% 127
2017
Q1
$729K Buy
10,726
+5,000
+87% +$352K 0.1% 127
2016
Q4
$410K Sell
5,726
-649
-10% -$48.2K 0.06% 207
2016
Q3
$504K Sell
6,375
-556
-8% -$45.2K 0.08% 171
2016
Q2
$578K Buy
6,931
+2,108
+44% +$187K 0.1% 141
2016
Q1
$443K Buy
4,823
+38
+0.8% +$3.43K 0.08% 175
2015
Q4
$484K Buy
+4,785
New +$498K 0.09% 157

Other funds holding GILD

Wealthspire Advisors (Maryland)'s GILD Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its Gilead Sciences (GILD) stake by 12% in Q3 2020, selling an estimated $83.1K and leaving 8,723 shares worth $551K. The position accounts for 0.02% of the portfolio, ranked #251.

Wealthspire Advisors (Maryland) first reported a position in GILD in Q4 2015 and has held it in 20 quarters since. The position peaked at $993K in Q3 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 8,723 shares of Gilead Sciences worth $551K as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 1,198 Gilead Sciences shares in Q3 2020, an estimated $83.1K.
  • Gilead Sciences made up 0.02% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #251 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Gilead Sciences in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s Gilead Sciences position peaked at $993K in Q3 2017.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.